Better Choice Company announced that after successfully completing the acquisition of Aimia, the company will explore and evaluate proposals to monetize and fund ownership in its R&D platform with the goal to bring in partners to participate in the evolution of a treat-based GLP1 supplement to combat obesity in dogs and cats.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BTTR:
- Better Choice to Explore Non-Equity Related Capital Solutions to Fund the R&D of its Domestic Animal Targeted GLP1 Supplement
- Better Choice Company Acquires Aimia to Combat Pet Obesity
- Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market
- Better Choice Company acquires Aimia Pet Healthco, terms not disclosed
